Data Reporting Problems

Similar documents
OUR JOURNEY THROUGH THE YEARS

The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca

storage and handling of unused stem cell products Swiss consensus?

Portal Technical Requirements

Umbilical Cord Blood Transplantation

Reference: NHS England B04/P/a

Corporate Medical Policy

Bone Marrow/Stem Cell Transplant

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

The CIBMTR Audit Program

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose

STEM CELL THERAPEUTIC OUTCOMES DATABASE

Corporate Medical Policy

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP)

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy

A Cure for Sickle Cell Anemia and Thalassemia

Background: 1) Does your center have effective ways of collecting data from multiple sources to submit to multiple organizations?

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma (CALM) Additional Questionnaire (MED C) INCLUSION CRITERIA CALM STUDY

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

The donor search: the best donor or cord blood unit

Outline of thesis and future perspectives.

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa

Infosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation?

How to select a donor and product for allogeneic HCT

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR

Integrating Quality Reporting into the Electronic Medical Record

On April 4, a group of physicians at the 37th annual

Challenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Selection of the Optimal Umbilical Cord Blood Unit

Blood-Forming Stem Cell Transplants

Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012

The Danish Bone Marrow Donor Registry DBMDR

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Stammzelltransplantation. Neues vom immunologischen Ctrl-Alt-Del

Treatment of low-grade non-hodgkin lymphoma

Epstein-Barr virus-associated lymphoproliferative disease following allogeneic stem cell transplantation

Are CAR T-Cells the Solution for Chemotherapy Refractory Diffuse Large B-Cell Lymphoma? Umar Farooq, MD University of Iowa Hospitals and Clinics

WBMT Global Survey. Helen Baldomero Cape Town November Worldwide Network for Blood and Marrow Transplantation

PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA

ILNA CODING GUIDELINES

EBMT European Society for Blood and Marrow Transplantation MED-AB FORMS MANUAL

Not for publication or presentation

cancer cancer Hessamfar-Bonarek M et al. Int. J. Epidemiol. 2010;39:

Graft Failure After HSCT

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April Reference: NHSCB/B04/P/a

Directed/Related Cord Blood Collection by NHS Blood and Transplant

Selecting an appropriately matched donor for hematopoietic

Lymphomas after organ transplantation

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS

UMBILICAL CORD BANKING. (formerly Unistem Biosciences Pvt.Ltd.)

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

Immunoablative therapy with autologous hematopoietic stem cell transplantation in the treatment of poor risk multiple sclerosis

New Zealand Bone Marrow Donor Registry

Chapter 2 History of MD Anderson s Tumor Registry

Epstein-Barr Virus (EBV) complications following HSCT: from viremia to post transplant lymphoproliferative disease (PTLD) and lymphoma

CSHCN Services Program Prior Authorization Request for Stem Cell or Renal Transplant Form and Instructions

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status

H. R IN THE HOUSE OF REPRESENTATIVES

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

NATIONAL CANCER DRUG FUND PRIORITISATION SCORES

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

Cord Blood Transplant. E. Gluckman Eurocord ESH-EBMT training course Vienna 2014

Preparing for the CIBMTR Data Audit

Health Disparities in Multiple Myeloma. Kenneth R. Bridges, M.D. Senior Medical Director Onyx Pharmaceuticals, Inc.

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

Workshop on Patient Support and Market Research Programmes

Cord blood donation is a painless and free gesture, helping others and saving lives.

Stem Cell Transplantation for Acute Lymphoblastic Leukemia

Graft-versus-host disease (GvHD)

What is a Stem Cell Transplantation?

Instructions for Pre-Transplant Essential Data (Pre-TED) Form (Revision 4) TABLE OF CONTENTS

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD

Safe Blood Sampling Training Package

How To Save A Patient From A Cancer

Transcription:

Data Reporting Problems Shelley Hewerdine & Khrystyna Valkiv Istanbul, 23rd March 2015 #EBMT2015 www.ebmt.org

Format of this session Recent EBMT Registry work Improving Data Quality Data reporting Quiz Your questions 2

How the data is used The Registry provides a pool of data to perform retrospective studies, assess epidemiological trends, or prepare prospective trials. Collected data on >500,000 transplants since they began in the 1970s. For basic and clinical Research Standardisation and Quality Control Accreditation (JACIE) Requirements - Health Authorities and Commissioners EBMT Membership requirements: MED-A for every transplant performed 3

Importance of good data Data as accurate and complete as possible for research and quality management Missing data and missing follow ups can skew data or lead to a statistical bias Follow up: very important part of the Registry, research helping to improve quality of life, long term. Example of centre reporting follow up only when something happens (Centre A) and a centre systematically reporting follow ups (Centre B): 4

Overall survival for Centres A and B 1.00 0.75 0.50 Centre B 0.25 Centre A 0.00 0 10 20 30 Years 5

1.00 Length of follow up Centres with same outcome may look worse when follow up is shorter 0.75 0.50 0.25 =< 5 years >10 years >5 and =<10 years 0.00 0 20 40 60 Years 6

Working to improve the data Tidy Up Your Data campaign. Have run a full list of data quality queries and sent to centres. (ProMISe users encouraged to run them to check data) 7

Tidy Up Your Data: list of report queries Diagnosis labelled as other or unknown (Main Classification only) Diagnosis sub classification labelled as other or unknown Best Response_Status after HSCT is Null and_or Unknown Disease status at HSCT is Null and_or Unknown Missing number of Disease status at HSCT No relapse prior to 2nd or subsequent HSCT Cause of death is GvHD but no GvHD recorded Cause of death is relapse but no relapse recorded Last assessment is HSCT assessment Patient alive with a cause of death Hospital or Unit unique patient number (UPN) missing Hospital unique patient number (UPN) shared by two patient records Patient date of birth missing Possible duplicate entry of same patient Allogeneic HSCT without a donor Source of stem cells missing 8

Working to improve the data: further requests Emailed all centres with a list of patients that have not had a follow up reported for 5 years or more. Aim to send these more regularly: twice a year Missing MED-A: requests sent to centres sending in data forms. Aim to widen requests to target more ProMISe users Duplicate registrations: many emails have been sent to query possible duplicates in centres and clean up the doubles Thank you for helping with our data quality requests 9

Quiz Quiz handouts 8 questions. Have a look in pairs or groups of 3 for approx 15-20 minutes 10

Quiz: Solutions 1. Which of the following should NOT be reported as a transplant registration? Answer b) Autologous reinfusion after graft failure This is not considered as a transplant. Check transplant definitions at the beginning of the MED-AB manual. Ask clinician or registry helpdesk if unsure. A boost is an infusion of cells from the same donor without conditioning, with the same donor being present in a proportion higher than 10% If cells are not from same donor OR there is conditioning OR donor cells are present at a lower proportion than 10%, then it is a genuine transplant. Please also report patients who die between conditioning and transplant. We enter the day 0 info and put the planned HSCT date as the date of death 11

Quiz: Solutions 2. A patient received Rituximab as a treatment for EBV or CMV reactivation, but you can t find this in the MED-A form, what should you do? This treatment is not part of the EBMT data collection. Can be entered in the database by advanced users, but unlikely to be analysed. Centres can record data for own use if preferred Recommendation: keep to MED-AB. And if you report MED-A but find you want to record MED-B items, report MED-B! 12

Quiz: Solutions 3. A patient has a rare diagnosis and you cannot find the right disease classification sheet or code. What do you do? Answer: b) Check the disease classifications list on the EBMT website If cannot find or unsure, answer c) Contact the registry helpdesk Answer a) Enter it in the database as uncoded is a no-no. It is very rare for diseases to be uncoded. Only enter an uncoded diagnosis if we advise you to. 13

Quiz: Solutions 4. In 2005 the percentage of transplant registrations with the best response at 100 days missing or unknown was 12%. Do you think this percentage has increased or decreased for recent registrations (2013 transplants)? Answer: decreased. The number of registrations with this item missing/unknown in 2013 was 7% Improvement over time: number of missing MED-A items decreased: 14

EBMT Registry Missing data items - average per HSCT Med-A submission 400 350 300 Number of centres 250 200 150 100 < 5 missing items 5-10 missing items >10 missing items 50 0 2011 2012 2013 2014 90% 80% 70% Percentage of centres 60% 50% 40% 30% 20% 10% 0% 2011 2012 2013 2014 < 5 missing items 5-10 missing items >10 missing items 15

Quiz: Solutions Remember you can run a report on the best response missing item, plus display records without disease status at transplant (and number of the status) properly filled. Crucial data quality reports on identifiers: Unique UPN per patient per centre Possible duplicates: all transplants need to go in one single patient record, no matter where performed or the number of transplants (Request form to access original transplant in other centre) Ensure date of birth and patient gender are filled 16

Quiz: Solutions 5. If a patient has more than one transplant, when should follow up be reported? Answer: b) Between transplants, then annually after the most recent transplant We will try to improve our data forms to help capture the follow up between transplants. Again a DQ report: No relapse prior to 2nd or subsequent HSCT 17

Quiz: Solutions 6. Donor Lymphocyte Infusions (DLI): Must all the infusions of the same regimen (given for the same indication within 10 weeks) be recorded separately, or must only the 1st infusion of the regimen be recorded with the total number of infusion in this regimen (without entering details for each infusion)? Answer: only the 1 st infusion of each 10 week cycle needs to be reported, giving the total number of infusions 18

Quiz: Solutions 7. What is the best way to send electronic data files to EBMT? E.g. scanned forms, HLA reports, Excel files with study or data queries Correct answer: b) send by email with password protection or c) use secure download facility in Promise. c) ideally best, available Promise 3. Answer a) Just send by email is a no-no for files containing identifiers, but continues to happen. 19

Quiz: Solutions 8. MED-A follow up form: discrepancies Cause of death is relapse, but relapse data not recorded. (Also may happen with gvhd). DQ reports available for both No date of last contact (also may happen with Excel requests) 20

Conclusions Positive response to Tidy Up Your Data and 5 Year follow up Decrease in number of missing items in MED-A Cleaning the duplicate registrations and shared UPNs. <400 possible doubles. Shared UPNs halved. Thank you for all your help and cooperation with the data, and the quality! 21

Your Questions? 22

Related Sessions EBMT 2015 Please complete feedback form.. then join us for a drink! Data Managers Reception Room 3B10 Tuesday 09:00 09:40 Changes to MED-A Please complete feedback forms 10:00 12:00 (computer room) HLA Data Entry 11.45 13:00 Introduction to HSCT and the MED-A form 14:00 15:30 (computer room) Avoiding & solving problems in ProMISe 14:45 15:25 Data Managers & Literature 23